Aerpio Pharmaceuticals, Inc.
TREATMENT OF OCULAR DISEASE
Last updated:
Abstract:
Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, retinal angiomatous proliferation, macular telangiectasia and uveitis.
Status:
Application
Type:
Utility
Filling date:
24 Jan 2020
Issue date:
23 Jul 2020